AGIOS PHARMACEUTICALS, INC. — Director's Dealing 2017

Sep 13, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AGIOS PHARMACEUTICALS INC (AGIO)
CIK: 0001439222
Period of Report: 2017-09-11

Reporting Person: Biller Scott (Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-09-11	Common stock	S	15000	$65.00	Disposed	10470	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common stock	6264	Direct

Footnotes

F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2: Shares held by a spousal lifetime access trust, of which the reporting person's wife is trustee.